Kelly Schlemm

Kelly Schlemm

Head of Communications and Public Affairs

Kelly Schlemm is the Head of Communications and Public Affairs at Servier Pharmaceuticals. Her focus is to devise integrated and aligned communications strategies with the aim of communicating across all stakeholders Servier’s progress, our vision for the future and the roadmap of how we intend to get there. Further, she plays a key role in shaping the company’s policy initiatives in alignment with Corporate Sustainability efforts. She strives daily to meet patient needs and ensure their voice is heard.

Kelly is an executive with wide experience in corporate communications, media relations, investor relations, business development, product and portfolio, brand strategy, crisis communications and public affairs. Kelly previously served as Director of Takeda’s R&D External and Innovation Network Communications. Her career is distinguished by extensive business development and corporate growth experience including leadership roles in the launch and growth of multiple startups from conception to multi-billion-dollar enterprises. She has held management positions across biotechnology and pharmaceutical companies and in communications agencies such as Shire, Baxalta and Ogilvy.

Kelly received her Bachelor of Arts in Communications from Seton Hall University.

To learn more about Kelly connect with her on LinkedIn.

More from Servier

About Us

Servier Pharmaceuticals is a privately held pharmaceutical company focused on oncology. Everything we do is to bring the promise of tomorrow to the patients we serve.

Learn More

Governance

Servier Pharmaceuticals is an independent, privately held United States company launched by Servier Group, a unique global organization, and is governed by a non-profit foundation.

Learn More

History

Servier has a 65-year history of helping provide innovative medicines to patients globally. In the United States, Servier intends to uphold and build upon that history. 

Learn More